|
Index of reports
> Cases with Maternal Exposure During Pregnancy (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Alfentanil where reactions include maternal exposure during pregnancy. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Alfentanil side effects in female
Reported by a physician from Sweden on 2011-10-13
Patient: female
Reactions: Fatigue, Maternal Exposure During Pregnancy, Respiratory Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Propavan
Tegretol
Alfentanil
Start date: 2011-07-13
End date: 2011-07-13
Nitrazepam
Venlafaxine HCL
Pentothal
Start date: 2011-07-13
End date: 2011-07-13
Succinylcholine Chloride
Start date: 2011-07-13
End date: 2011-07-13
Zolpidem Tartrate
Baclofen
Lyrica
Other drugs received by patient: Folacin / 00024201 /; Cilaxoral; Kalcipos; Trandate
Possible Alfentanil side effects in female
Reported by a physician from Sweden on 2011-10-06
Patient: female
Reactions: Fatigue, Maternal Exposure During Pregnancy, Respiratory Depression
Drug(s) suspected as cause:
Succinylcholine Chloride
Dosage: 100 mg, single
Start date: 2011-07-13
End date: 2011-07-13
Lyrica
Dosage: 350 mg daily
Zolpidem Tartrate
Dosage: 10 mg daily
Nitrazepam
Dosage: 5 mg, 1x/day
Baclofen
Dosage: 10 mg daily
Venlafaxine
Dosage: 75 mg daily
Pentothal
Dosage: 500 mg, single
Start date: 2011-07-13
End date: 2011-07-13
Propavan
Dosage: 25 mg, 1x/day
Tegretol
Dosage: 1800 mg daily
Indication: Epilepsy
Alfentanil
Dosage: 0.5 mg
Start date: 2011-07-13
End date: 2011-07-13
Other drugs received by patient: Kalcipos-D; Folic Acid; Trandate; Cilaxoral
|
